Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO) | NeoGenomics Laboratories

Publication date

Thu, 09/29/2022 - 12:00

Year

Subtitle

ESMO 2022

File

Updated_follow-up_data_and_biomarker_analysis_of_pre-operative_ipilimumab_and_nivolumab_in_locoregional_advanced_urothelial_cancer.pdf (905.79 KB)

Division